The effect of intravitreal adalimumab injection on pseudophakic macular edema
Not Applicable
- Conditions
- Pseudophakic macular edema.Other specified retinal disorders
- Registration Number
- IRCT2016100430130N1
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
patients with pseudophakic macular edema and PCIOL in bag who have received prior treatment (topical NSAIDs or topical corticosteroids). Exclusion criteria: patients with macular edema due to causes other than pseudophakia(diabetes, uveitis, retinitis pigmentosa); complicated surgery (vitrous loss); PCIOL in sulcus and ACIOL.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity. Timepoint: Before injection, 1 week and 1 month after injection. Method of measurement: Snellen chart.
- Secondary Outcome Measures
Name Time Method Central macular thickness. Timepoint: Before injection, 1 week and 1 month after injection. Method of measurement: OCT.